Clinical Trials
14 trialsNCT04116502 2026-04-28
MITHRIDATE
University of Birmingham
Phase 3 Recruiting
NCT04534725 2023-08-24
C-SMART
Peter MacCallum Cancer Centre, Australia
Phase 3 Completed
NCT00002835 2018-11-15
Combination Chemotherapy in Treating Patients With Lymphoma
M.D. Anderson Cancer Center
Phase 3 Completed
NCT01681446 2018-06-01
Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression
Fudan University
Phase 3 Unknown
NCT00055874 2018-05-03
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Heidelberg University
Phase 3 Completed
NCT00209209 2017-03-07
MCLelderly
European Mantle Cell Lymphoma Network
Phase 3 Unknown
NCT00072046 2016-07-06
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00004196 2014-01-20
Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
University of Alabama at Birmingham
Phase 3 Completed
NCT00447356 2013-05-13
High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma
Hackensack Meridian Health
Phase 3 Withdrawn
NCT00416871 2012-09-26
Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer
Centre Leon Berard
Phase 3 Completed
NCT00002882 2011-12-13
Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma
M.D. Anderson Cancer Center
Phase 3 Completed
NCT01060501 2010-02-02
FOGT1
University of Ulm
Phase 3 Completed
NCT00633542 2008-03-12
Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)
Università Politecnica delle Marche
Phase 3 Completed
NCT00291369 2006-02-16
Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis
Centre Leon Berard
Phase 3 Completed